Insulin Lispro Sanofi

Insulin lispro, the active ingredient in Insulin Lispro Sanofi, is a rapid‑acting insulin analog presented as a solution for subcutaneous use. Its rapid onset of action mimics natural insulin release after meals, helping to achieve post‑prandial glucose control. It is used to lower blood glucose levels in patients with diabetes mellitus, both Type 1 and Type 2.

GNH USA supplies Insulin Lispro Sanofi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Insulin lispro is a rapid‑acting insulin analog used in the management of diabetes mellitus, targeting post‑prandial glucose excursions. - Type 1 diabetes mellitus: provides rapid mealtime insulin to achieve tight glycemic control. - Type 2 diabetes mellitus: used as bolus insulin in combination with basal therapy to improve post‑prandial glucose levels.

Insulin lispro may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Hypoglycemia: low blood sugar episodes, especially if meals are missed or delayed. - Injection site reactions: redness, swelling, or itching at the injection site. - Weight gain: modest increase due to improved glucose utilization. - Lipodystrophy: localized changes in fat tissue at injection sites. - Nausea: occasional gastrointestinal discomfort.

Serious or Rare Side Effects: - Severe hypoglycemia: can lead to loss of consciousness or seizures. - Anaphylactic reaction: rare but potentially life‑threatening allergic response. - Insulin antibodies: may alter insulin effectiveness. - Edema: abnormal fluid accumulation in extremities.

When using Insulin Lispro Sanofi, several precautions should be observed to ensure safe and effective therapy. - Dose adjustment: tailor dose to individual carbohydrate intake and blood glucose monitoring. - Hypoglycemia risk: monitor for signs of low blood sugar, especially when meals are delayed. - Concomitant alcohol: avoid excessive alcohol as it can potentiate hypoglycemia. - Pregnancy and lactation: use only if benefits outweigh risks, after medical evaluation. - Store at 2‑8 °C: keep refrigerated, protect from light, do not freeze or shake.

Insulin lispro can interact with other medicines, altering its glucose‑lowering effect or increasing adverse reactions.

Major Interactions (Avoid): - Beta‑blockers: may mask symptoms of hypoglycemia, requiring closer glucose monitoring. - Alcohol: can potentiate insulin’s hypoglycemic effect, increasing risk of severe low blood sugar.

Moderate Interactions (Monitor Closely): - Thiazide diuretics: may reduce insulin sensitivity, necessitating dose adjustments. - Corticosteroids: can raise blood glucose, potentially requiring higher insulin doses. - Oral contraceptives: may affect insulin requirements, warranting regular monitoring.